[Bcl-2 gene expression in endometrial carcinoma].
To evaluate the relationship between bcl-2 gene and endometrial carcinoma. Immunohistochemical staining was performed on formalin-fixed paraffin-embedded tissue sections. A monoclonal antibody to the bcl-2 gene product was used, the signal was detected using a streptavidin-biotin complex with aminoethylcarbazole. There were 15 cases of endometrial atypical hyperplasia and 50 cases of endometrial carcinoma examined. Bcl-2 expression was high in endometrial atypical hyperplasia, whereas bcl-2 expression was low in endometrial carcinoma. In endometrial carcinoma, with progression of clinical stage, decreased histologic grade and deepening of cancer invasion, the positive rate of bcl-2 expression was correspondingly decreased. Bcl-2 plays a role in the genesis of endometrial carcinoma especially at the initial stage.